Acura Pharmaceuticals, Inc.
ACUR
$0.0023
$0.00014.55%
09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 89.00K | 167.00K | 361.00K | 413.00K | 493.00K |
Total Receivables | 540.00K | 1.11M | 934.00K | 627.00K | 921.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 216.00K | 28.00K | 84.00K | 139.00K | 209.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 845.00K | 1.31M | 1.38M | 1.18M | 1.62M |
|
|||||
Total Current Assets | 845.00K | 1.31M | 1.38M | 1.18M | 1.62M |
Net Property, Plant & Equipment | 508.00K | 527.00K | 473.00K | 484.00K | 498.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 53.00K | 60.00K | 66.00K | 73.00K | 78.00K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 1.41M | 1.90M | 1.92M | 1.74M | 2.20M |
|
|||||
Total Accounts Payable | 135.00K | 205.00K | 65.00K | 31.00K | 284.00K |
Total Accrued Expenses | 771.00K | 673.00K | 1.46M | 1.31M | 721.00K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 33.00K | 197.00K | 6.16M | 6.16M | 164.00K |
Total Finance Division Other Current Liabilities | 41.00K | 35.00K | -- | 18.00K | 16.00K |
Total Other Current Liabilities | 41.00K | 35.00K | -- | 18.00K | 16.00K |
Total Current Liabilities | 980.00K | 1.11M | 7.68M | 7.52M | 1.19M |
|
|||||
Total Current Liabilities | 980.00K | 1.11M | 7.68M | 7.52M | 1.19M |
Long-Term Debt | 266.00K | 371.00K | 371.00K | 105.00K | 6.11M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 25.00K | 33.00K | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | 566.00K |
Total Liabilities | 1.27M | 1.51M | 8.06M | 7.63M | 7.86M |
|
|||||
Common Stock & APIC | 390.25M | 390.23M | 383.33M | 383.31M | 383.30M |
Retained Earnings | -390.11M | -389.85M | -389.46M | -389.20M | -388.96M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 135.00K | 382.00K | -6.14M | -5.89M | -5.66M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 135.00K | 382.00K | -6.14M | -5.89M | -5.66M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 135.00K | 382.00K | -6.14M | -5.89M | -5.66M |
|